Identifies plasma biomarkers for atrial fibrillation in stroke patients, suggesting diagnostic potential.
To identify a plasma biomarkers signature that discriminates between IS/TIA patients with and without a history of AFib using quantitative proteomics.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: